THP1-HMGB1-Lucia™ Cells

THP1-HMGB1-Lucia™ Cells Unit size Cat. code Docs Qty Price
Pyroptosis and necroptosis reporter monocytes
3-7 x 10e6 cells

You may also need : Normocin™ - Antimicrobial Reagent | View more associated products

Pyroptosis and necroptosis reporter monocytes

THP1-HMGB1-Lucia™ cells are designed to monitor necroptosis and inflammasome-mediated pyroptosis, two forms of necrotic cell death characterized by the release of the alarmin HMGB1 (High Mobility Group Box-1) upon cell membrane rupture.

Pyroptosis is a consequence of inflammasome activation.
Typically, inflammasome activation is a two-step process. A first signal (‘priming’), provided by microbial molecules such as lipopolysaccharide (LPS), induces NF-κB-dependent expression of pro-IL1β. The second signal, provided by structurally unrelated microbial molecules (e.g. Nigericin toxin) or danger signals, triggers inflammasome multimerization. This leads to caspase-1 self-activation, proteolytic maturation of IL-1β and IL-18, and cleavage of Gasdermin D (GSDMD). Subsequent GSDMD pore formation at the cell membrane elicits a rapid cell death associated with the release of IL-1β, IL-18, and HMGB1 [1,2].

Necroptosis is mainly implicated in conditions of disease or infection and is triggered by the formation of a necrosome. The necrosome is induced upon Tumor Necrosis Factor (TNF) receptor or PRR activation in absence of caspase-8 and cIAP (cellular inhibitor of apoptosis) activity. The necrosome contains receptor-interacting serine/threonine-protein kinases RIPK1 and RIPK3, and the mixed lineage kinase-like MLKL. Phosphorylated MLKL relocalizes at the plasma membrane where it drives cell lysis and release of HMGB1, most probably through pore formation [3]. 

THP1-HMGB1-Lucia™ cells are derived from the THP-1 human monocytic cell line and stably express a HMGB1::Lucia-luciferase fusion protein. These cells respond to commonly used inflammasome inducers and necroptosis cocktail inducers. The release of the HMGB1::Lucia protein in the extracellular milieu upon pyroptosis or necroptosis can be readily measured using the QUANTI-Luc™ detection reagent.
Levels of IL-1β can be measured by Western blot, ELISA or using InvivoGen’s HEK-Blue™ IL-1β cellular assay. Alternatively, secreted IL-18 can be detected using InvivoGen’s HEK-Blue™ IL-18 cellular assay.

THP1-HMGB1-Lucia™ cells are resistant to Zeocin™.



1. Broz P. and Dixit V.M., 2016. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 16:407-20.
2. Kovacs S.B. and Miao E.A., 2017. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 27:673-84.
3. Grootjans S. et al., 2017. Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ. 24:1184-95.


Pyroptosis and necroptosis pathways
Pyroptosis and necroptosis pathways
Evaluation of inflammasome mediated-pyroptosis
Evaluation of inflammasome mediated-pyroptosis

Pyroptosis response of THP1-HMGB1-Lucia™ cells. Cells were primed with 1 μg/ml LPS-EK for 3 hours and then incubated with inflammasome inducers : 0.5 μg/ml complexed Poly(dA:dT) (left panel) or 8 μM Nigericin (right panel). Lucia luciferase activity and LDH release in the supernatant were quantified at 2, 3, 4, 5 and 6 hours post-induction. The Lucia luciferase activity was determined by measuring relative light units (RLUs) in a luminometer using QUANTI-Luc™ detection reagent. Results are presented as the fold increase over non-induced cells. The LDH release was determined using a commercially available LDH cytotoxicity assay. Results are presented as percentage of the maximal LDH release measured in positive control.

Necroptosis response of THP1-HMGB1-Lucia™ cells. Cells were pre-treated with the pan-caspase inhibitor Z-VAD-FMK (25 μM) for 1 hour prior to incubation with TNF-α (100 ng/ml) alone or in combination with the cIAP inhibitor BV6 (5 μM). As a control of necroptosis induction, Necrostatin 1(NS1; 30 μM), a necroptosis inhibitor was added to the TNF-α and cIAP mix. Eight hours later,, the Lucia luciferase activity was determined by measuring RLUs in a luminometer using QUANTI-Luc™ detection reagent. Results are presented as the fold increase over non-treated cells.

Back to the top


Growth medium: RPMI 1640, 2 mM L-glutamine, 25 mM HEPES, 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml streptomycin,100 μg/ml Normocin™

Antibiotic resistance: Zeocin™

Quality control:

  • The functionality of THP1-HMGB1-Lucia™ cells was tested using inflammasome inducers, such as Nigericin.
  • The stability of this cell line for 20 passages following thawing has been verified.
  • THP1-HMGB1-Lucia™ cells are guaranteed mycoplasma-free

This product is covered by a Limited Use Licence (See Terms and Conditions).

Back to the top


  • 3-7 x 106 THP1-HMGB1-Lucia™ cells in a cryovial or shipping flask
  • 1 ml Normocin™ (50 mg/ml). Normocin™ is a formulation of three antibiotics active against mycoplasmas, bacteria, and fungi.
  • 100 µl Zeocin™ (100 mg/ml).
  • 1 pouch of QUANTI-Luc™ (Lucia luciferase detection medium)

Shipped on dry ice (Europe, USA & Canada)

Back to the top


Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty